Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels
- PMID: 35771623
- DOI: 10.1111/bph.15913
Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels
Abstract
Background and purpose: Atopic dermatitis (AD) is one of the most common chronic inflammatory cutaneous diseases with unmet clinical needs. As a common ingredient found in several medicinal herbs with efficacy on cutaneous inflammatory diseases, Scutellarein (Scu) has been shown to possess anti-inflammatory and anti-proliferative activities. We aimed to evaluate the therapeutic efficacy of Scu against AD and its underlying molecular mechanism.
Experimental approach: Efficacy of Scu on AD was evaluated in 2,4-dinitrofluorobenzene (DNFB) and carvacrol-induced dermatitis mouse models. Cytokine mRNA and serum IgE levels were examined using qPCR and ELISA, respectively. Voltage clamp recordings were used to measure currents mediated by transient receptor potential (TRP) channels. In silico docking, site-direct mutagenesis, and covalent modification were used to explore the binding pocket of Scu on TRPV3.
Key results: Subcutaneous administration of Scu efficaciously suppresses DNFB and carvacrol-induced pruritus, epidermal hyperplasia and skin inflammation in wild type mice but has no additional benefit in Trpv3 knockout mice in the carvacrol model. Scu is a potent and selective TRPV3 channel allosteric negative modulator with an apparent affinity of 1.18 μM. Molecular docking coupled with site-direct mutagenesis and covalent modification of incorporated cysteine residues demonstrate that Scu targets the cavity formed between the pore helix and transmembrane helix S6. Moreover, Scu attenuates endogenous TRPV3 activity in human keratinocytes and inhibits carvacrol-induced proliferative and proinflammatory responses.
Conclusion and implications: Collectively, these data demonstrate that Scu ameliorates carvacrol-induced skin inflammation by directly inhibiting TRPV3, and TRPV3 represents a viable therapeutic target for AD treatment.
Keywords: TRPV3; atopic dermatitis; keratinocytes; scutellarein.
© 2022 British Pharmacological Society.
Similar articles
-
Inhibition of the Warm Temperature-Activated Ca2+-Permeable Transient Receptor Potential Vanilloid TRPV3 Channel Attenuates Atopic Dermatitis.Mol Pharmacol. 2019 Sep;96(3):393-400. doi: 10.1124/mol.119.116962. Epub 2019 Jul 15. Mol Pharmacol. 2019. PMID: 31308264
-
TRPV3 enhances skin keratinocyte proliferation through EGFR-dependent signaling pathways.Cell Biol Toxicol. 2021 Apr;37(2):313-330. doi: 10.1007/s10565-020-09536-2. Epub 2020 Jun 13. Cell Biol Toxicol. 2021. PMID: 32535744
-
Inhibition of transient receptor potential vanilloid 3 channels by antimalarial hydroxychloroquine alleviates TRPV3-dependent dermatitis.J Biol Chem. 2024 Oct;300(10):107733. doi: 10.1016/j.jbc.2024.107733. Epub 2024 Sep 2. J Biol Chem. 2024. PMID: 39233228 Free PMC article.
-
TRPV3 and Itch: The Role of TRPV3 in Chronic Pruritus according to Clinical and Experimental Evidence.Int J Mol Sci. 2022 Nov 29;23(23):14962. doi: 10.3390/ijms232314962. Int J Mol Sci. 2022. PMID: 36499288 Free PMC article. Review.
-
Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.Front Immunol. 2021 Jun 30;12:696784. doi: 10.3389/fimmu.2021.696784. eCollection 2021. Front Immunol. 2021. PMID: 34276687 Free PMC article. Review.
Cited by
-
Sodium Butyrate Ameliorates Atopic Dermatitis-Induced Inflammation by Inhibiting HDAC3-Mediated STAT1 and NF-κB Pathway.Inflammation. 2024 Jun;47(3):989-1001. doi: 10.1007/s10753-023-01955-7. Epub 2023 Dec 30. Inflammation. 2024. PMID: 38159175
-
Inhibition of Cutaneous TRPV3 Channels by Natural Caffeic Acid for the Alleviation of Skin Inflammation.Molecules. 2024 Aug 6;29(16):3728. doi: 10.3390/molecules29163728. Molecules. 2024. PMID: 39202808 Free PMC article.
-
Plant essential oil targets TRPV3 for skin renewal and structural mechanism of action.Nat Commun. 2025 Mar 19;16(1):2728. doi: 10.1038/s41467-025-58033-9. Nat Commun. 2025. PMID: 40108208 Free PMC article.
-
Repositioning Fluoxetine as a TRPV3 Channel Inhibitor to Alleviate Skin Inflammation and Pruritus.Curr Issues Mol Biol. 2025 Apr 15;47(4):277. doi: 10.3390/cimb47040277. Curr Issues Mol Biol. 2025. PMID: 40699677 Free PMC article.
-
Scutellarein ameliorates dextran sulfate sodium-induced ulcerative colitis by inhibiting colonic epithelial cell proinflammation and barrier disruption.Front Pharmacol. 2024 Oct 21;15:1479441. doi: 10.3389/fphar.2024.1479441. eCollection 2024. Front Pharmacol. 2024. PMID: 39502535 Free PMC article.
References
REFERENCES
-
- Aijima, R., Wang, B., Takao, T., Mihara, H., Kashio, M., Ohsaki, Y., Zhang, J. Q., Mizuno, A., Suzuki, M., Yamashita, Y., Masuko, S., Goto, M., Tominaga, M., & Kido, M. A. (2015). The thermosensitive TRPV3 channel contributes to rapid wound healing in oral epithelia. The FASEB Journal, 29(1), 182-192. https://doi.org/10.1096/fj.14-251314
-
- Alexander, S. P., & Mathie, A. (2021). The concise guide to pharmacology 2021/22: Ion channels. British Journal of Pharmacology, 178(Suppl 1), S157-s245. https://doi.org/10.1111/bph.15539
-
- Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., MacEwan, D. J., Mangum, J., Wonnacott, S., & Ahluwalia, A. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of pharmacology. British Journal of Pharmacology, 175(3), 407-411. https://doi.org/10.1111/bph.14112
-
- Asakawa, M., Yoshioka, T., Hikita, I., Matsutani, T., Hirasawa, T., Arimura, A., Sakata, T., & Horikawa, T. (2005). WBN/Kob-Ht rats spontaneously develop dermatitis under conventional conditions: Another possible model for atopic dermatitis. Experimental Animals, 54(5), 461-465. https://doi.org/10.1538/expanim.54.461
-
- Bang, S., Yoo, S., Yang, T. J., Cho, H., & Hwang, S. W. (2011). Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels. Pain, 152(5), 1156-1164. https://doi.org/10.1016/j.pain.2011.01.044
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials